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Introduction
Osteoporosis is a multifactorial skeletal disease characterised by low
bone mass and micro architectural deterioration, leading to increased
fracture susceptibility [1,2]. In Malta, 20% of women and 6% of men
aged 50 years and older are estimated to be affected with Osteoporosis
[3]. Fracture is the most significant clinical consequence of
osteoporosis, with the most common, debilitating, and costly fractures
being those of the spine, hip and wrist [1]. A number of environmental
and genetic risk factors are known to affect bone mineral density
(BMD), which in turn impacts fracture outcome [4,5]. Furthermore,
other parameters reflecting calcium homeostasis, matrix
mineralisation, and bone formation can also be targeted and measured
in blood. Levels of serum calcium, serum albumin, and total serum
alkaline phosphatase (sALP) are suggested as potential indicative
markers of osteoporosis and/or fracture susceptibility, and increased
frailty [5,6].
The role of calcium and albumin in bone
Bone is a versatile, physiologically dynamic organ composed of an
inorganic phase (60-70%) and an organic phase (30-40%). Most of the
inorganic phase (90-95%) consists of calcium hydroxyapatite
(Ca10(PO4)6(OH)2) and to a much lesser extent of water and
impurities [7]. The hydroxyapatite crystals interact with water in the
bonematrix and extracellular fluid for the exchange of ions to aid in
bone mineralisation. The organic phase, also known as the
extracellular matrix (ECM), is mainly composed of type I collagen, a
smaller portion of non-collagenous proteins (15%), as well as
specialised proteins such as proteoglycans, growth factors, and matrix
metalloproteinases. One-fourth of the total non-collagenous protein
content is composed of exogenous albumin, which affects matrix
mineralisation and bone cell proliferation thereby controlling
hydroxyapatite crystal growth [8]. These protein levels also affect levels
of Insulin Growth Factor 1 (IGF-1), which in turn play a role in bone
remodeling [9].
Metabolically, this endocrine organ is primarily a major source of
minerals, particularly calcium and phosphorus, which are involved
extensively in calcium and phosphate homeostasis, to an extent that
bone is compromised in favour of maintaining a constant serum
calcium level in the body. The key players involved in this bone
calcium mobilisation are parathyroid hormone (PTH) and vitamin D
[10], which promptly come into play to normalise serum calcium levels
by increasing or decreasing calcium losses through the intestines and
kidneys [11]. Indeed, two scenarios are possible. In primary
postmenopausal bone loss, serum calcium levels increase due to the
increased bone resorption rate. To compensate for the high serum
calcium level, PTH levels are low thereby decreasing gastrointestinal
and/or tubular calcium reabsorption [11]. In addition, a decline in
oestrogen at menopausedecreases plasma volume due to an increase in
urinary output, which in turnincreases serum albumin concentration
[12]. Since blood calcium is primarily bound to albumin, higher
circulatory total calcium levels are seen at menopause [13]. In fact,
Maltese postmenopausal women below the age of 60 years were found
to have considerably higher total serum calcium levels, which were
negatively correlated with hip BMD [6]. Conversely, with ageing, a
decline in gastrointestinal and/or tubular reabsorption of calcium
results in an overall decline in serum calcium levels. To counterbalance
the low serum calcium levels, calcium is mobilized from bone
following secondary increases in PTH and subsequently vitamin D
[14]. This results in osteoporosis and an increased fracture risk.
Maltese postmenopausal women above the age of 60 years, who
sustained more than one fracture or an osteoporotic hip fracture, had
the lowest serum calcium levels when compared to age-matched
controls [6]. Similar results were observed for serum albumin levels in
women with a fracture history, with lowest levels observed in those
who sustained a hip fracture. Lowest levels were recorded in older
postmenopausal women [6] indicating that a low protein intake and
possibly malnutrition negatively affect bone health [15]. The
association between low protein levels and hip fracture risk in the
elderly is well known [15,16], with authors reporting the use of serum
albumin as a marker of frailty [16]. However, the association with
BMD is still inconclusive [6,17]. A decline in the overall well-being and
functional status in older individuals due to malnutrition, distress, and
coexisting secondary disorders, is also accompanied by a decrease in
levels of calcium and albumin amongst others [18].
Total sALP and BMD
Total sALP is frequently used as a marker of bone metabolism
reflecting osteoblast activity and hence new bone formation. Maltese
postmenopausal women with an osteoporotic BMD at the hip and who
sustained an osteoporotic hip fracture had lower total sALP levels in
comparison to age-matched controls [6]. The use of sALP as a specific
marker of fracture risk remains controversial, with most studies
reporting no association [19,20]. It is important to note the time at
which blood is collected, since sALP levels return back to baseline
approximately ≥8 weeks post-fracture or possibly remain elevated in
the case or delayed or non-union fractures [19,20], therefore giving
falsely elevated results.
Physical activity and levels of serum calcium, albumin
and total sALP
Physical activity, especially weight-bearing exercise, is a well-known
determinant of healthy bone mass and increased bone strength. Low
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physical activity is thus considered a significant risk factor for low
BMD and increased fracture risk, most importantly at the hip [21].
Levels of serum biochemical parameters are also correlated with levels
of physical activity. Reduced physical activity and immobilization
favour osteclastogenesis, thereby decreasing osteoblast stimulation and
sALP levels [22]. Serum calcium and albumin levels are also affected by
the rate of physical activity performed. High physical activity is
associated with intermittent PTH stimulation, which increases calcium
absorption (reducing bone calcium mobilisation) and increases IGF-1
levels, which translate into higher albumin levels [23]. Indeed, Maltese
postmenopausal women who reported a low level of physical activity
had reduced levels of all three biochemical parameters [6].
Conclusion
In conclusion, levels of total serum calcium, albumin and sALP are
suggestive of possible markers of hip BMD and/or increased fracture
risk.
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